ORTEXORTEX News
Tracking ANET? Get live short interest, options flow, and signals on ORTEX.Sign up free →
AN
Trader NoteANET

Arista Earns a Post-Results Bounce, but the Street Is Divided on Price

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 4 min readdata as of 4 Nov 2026, 20:00

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Arista Networks reported Q3 results on November 3, the stock dropped sharply into the print and has since clawed back some ground, but the analyst community that emerged from the other side is not reading from the same page.

The share price tells the first part of the story. Arista closed at $169.91 on November 3, up 3.5% on the day, yet still down 9.1% over the week and 18% over the past month. The month-long slide is the more significant context: it brought the stock from above $200 to levels not seen since earlier in the year, and it did so without meaningful short-seller involvement. Short interest remains under 1% of the free float at 0.99%, and while it has edged up 6.2% over the week, the absolute level is too low to carry any directional signal. Borrowing costs fell sharply, down nearly 39% over the week to 0.59%, and availability remains effectively unlimited. The lending market has nothing to say about this stock right now. The selling pressure across October was driven by existing holders reassessing, not by new bears building positions.

The more consequential data is what happened on the analyst side after the results. The direction of target-price moves is split, and that split is worth attention. JP Morgan's Samik Chatterjee lifted his target to $270 from $250 and held his Overweight rating. Morgan Stanley raised to $230 from $220. Piper Sandler moved to $261 from $240. Set against those increases, Barclays cut sharply, taking its target to $236 from $289 while keeping an Overweight. Wells Fargo trimmed to $245 from $255. The consensus mean price target is $245, implying roughly 44% upside from the current price. That gap is real, but it reflects how much the stock has fallen over the past month rather than a sudden burst of analyst optimism. The broad picture is a Street that remains constructive on the name but is recalibrating what the results actually delivered.

The fundamental tension the Street is working through comes down to concentration and cost. The bull case rests on management's upgraded 2026 revenue growth guidance of 27.7% and $3.5 billion in AI revenue guidance, with operating margins running near 46% to 47% and $6.2 billion in deferred revenue providing visibility. The bear case points to the same numbers from a different angle: Microsoft and Meta account for a disproportionate share of revenue, leaving quarterly results vulnerable to shifts in hyperscaler capex plans. Barclays' sharp target cut after the print likely reflects concern that management's willingness to invest through the quarter, shipping revenue at the expense of near-term margin, creates execution risk that the prior $289 target had not priced in. Valuation multiples have compressed considerably: the price-to-earnings ratio has fallen roughly nine points over the past month to 33x, and the price-to-book has dropped more than two points to 9.4x. That compression is the market doing the repricing that the analysts are now catching up with.

One ownership detail is worth noting. Andreas Bechtolsheim, the company's co-founder and largest individual shareholder with 14.3% of shares, sold approximately $40 million of stock on October 30 across multiple tranches at prices between $167 and $174. All transactions were conducted under a pre-arranged 10b5-1 plan, which means they were scheduled in advance and do not carry the same signatory weight as a discretionary sale. CEO Jayshree Ullal's last reported position showed a reduction of roughly 2.9 million shares, though that filing date is October 9 and predates the Q3 report. The 90-day net across all insiders runs to minus $225 million in value, the bulk of which is Bechtolsheim's systematic disposals rather than any new change in conviction following the results.

Options positioning has edged further into defensive territory post-results. The put/call ratio closed at 1.01, the highest reading of the past year and 1.7 standard deviations above its 20-day average of 0.93. That is a continuation of the trend described in last week's pre-earnings notes rather than a new development, and at this level it reflects residual caution from holders who are unsure whether the results resolved the debate or simply reset it. Peers felt the same sector pressure: CIEN fell 14.5% over the week, LITE dropped 21.5%, and SILC gave back 24.1%, suggesting the selloff across networking names was broad. Arista's 9.1% weekly decline was actually one of the smaller moves in the peer group, a point that the flat-to-higher analyst targets may be reflecting. The next earnings event is scheduled for February 12, 2027, giving the revised guidance roughly three months to show up in the data before the Street has to revisit its models again.

Stocks in this article

See the live data behind this article on ORTEX.

Open ANET on ORTEX →

How this article was generated

Generated
4 Nov 2026, 20:00
Data as of
4 Nov 2026, 20:00
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.